Intracavernous pharmacotherapy for impotence: Selection of appropriate agent and dose

Journal of Urology

Volumn 149, Issue 5 SUPPL., 1993, Pages 1288-1290

  Von Heyden, B ^a   Donatucci, C F ^a   Kaula, N ^a   Lue, T F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

alprostadil; papaverine; penile erection; phentolamine; prostaglandins

Indexed keywords

PAPAVERINE; PHENTOLAMINE; PROSTAGLANDIN E1;

ADULT; AGED; ARTICLE; COMBINATION CHEMOTHERAPY; CORPUS CAVERNOSUM; DOSE RESPONSE; DRUG EFFICACY; HUMAN; HUMAN TISSUE; IMPOTENCE; INJECTION PAIN; MAJOR CLINICAL STUDY; MALE; MALE SEXUAL DYSFUNCTION; PENIS ERECTION; PEYRONIE DISEASE; PRIAPISM; PRIORITY JOURNAL; VASODILATATION;

EID: 0027278137     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(17)36370-X     Document Type: Article

References (23)

1. K.-P. Jünemann P. Alken Pharmacotherapy of erectile dysfunction: a review Int. J. Impotence Res. 1 1989 71
2. S.B. Levine S.E. Althof L.A. Turner C.B. Risen D.R. Bodner E.D. Kursh M.I. Resnick Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence J. Urol. 141 1989 54
3. N. Ishii H. Watanabe C. Irisawa Y. Kikuchi S. Kawamura K. Suzuki R. Chiba M. Tokiwa M. Shiiai Studies on male sexual impotence. Report 18. Therapeutic trial with prostaglandin E1 for organic impotence Jap. J. Urol. 77 1986 954
4. W. Stackl R. Hasun M. Marberger Intracavernous injection of prostaglandin E1 in impotent men J. Urol. 140 1988 66
5. T.F. Lue Impotence: a patient’s goal-directed approach to treatment World J. Urol. 8 1990 67
6. A.H. Bennett A.J. Carpenter J.H. Barada An improved vasoactive drug combination for a pharmacological erection program J. Urol. 146 1991 1564
7. C.F. Donatucci T.F. Lue The combined intracavernous injection and stimulation test: diagnostic accuracy J. Urol. 148 1992 61
8. T.F. Lue S.C. Mueller Y.R. Jow T.I. Hwang Functional evaluation of penile arteries with duplex ultrasound in vasodilator-induced erection Urol. Clin. N. Amer. 16 1989 799
9. J.A. Lopez M.A. Espeland J.P. Jarow Interpretation and quantification of penile blood flow studies using duplex ultrasonography J. Urol. 146 1991 1271
10. Juenemann, K. P.: Pharmacotherapy of impotence: where are we going? In: World Book on Impotence Research: Basic and Clinical. Edited by T. F. Lue. London: Smith Jordan & Co., Ltd., in press.
11. M. Waldhauser P. Schramek Efficacy and side effects of prostaglandin E1 in the treatment of erectile dysfunction J. Urol. 140 1988 525
12. P. Schramek R. Dorninger M. Waldhauser P. Konecny P. Porpaczy Prostaglandin E1 in erectile dysfunction. Efficiency and incidence of priapism Brit. J. Urol. 65 1990 68
13. A.A. Sidi J.S. Cameron L.M. Duffy P.H. Lange Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients J. Urol. 135 1986 704
14. C.G. Stief U. Wetterauer Erectile responses to intracaver nous papaverine and phentolamine: comparison of single and combined delivery J. Urol. 140 1988 1415
15. M. Abozeid K.-P. Juenemann J.-A. Luo T.F. Lue T.-S. Yen E.A. Tanagho Chronic papaverine treatment: the effect of repeated injections on the simian erectile response and penile tissue J. Urol 138 1987 1263
16. E.J.H. Meulemann B.L.H. Bemelmans W.H. Doesburg W.N.J.C. van Asten S.H. Skotnicki F.M.J. Debruyne Penile pharmaco-duplex-ultrasonography: a dose-effect study comparing papaverine, papaverine/phentolamine and prostaglandin E1 J. Urol. 147 part 2 1992 308A abstract 383
17. T.I.-S. Hwang C.-R. Yang S.-J. Wang C.-L. Chang T.-S. Tzai C.-H. Chang H.-C. Wu Impotence evaluated by the use of prostaglandin E1 J. Urol. 141 1989 1357
18. P. Schramek M. Waldhauser Dose-dependent effect and side-effect of prostaglandin E1 in erectile dysfunction Brit. J. Clin. Pharmacol. 28 1989 567
19. N. Ishii H. Watanabe C. Irisawa Y. Kikuchi Y. Kubata S. Kawamura K. Suzuki R. Chiba M. Tokiwa M. Shirai Intracavernous injection of prostaglandin E1 for the treatment of erectile impotence J. Urol. 141 1989 323
20. M.F. Sarosdy C.H. Hudnall D.R. Erickson T.C. Hardin D.E. Novicki A prospective double-blind trial of intracorporeal papaverine versus prostaglandin E1 in the treatment of impotence J. Urol. 141 1989 551
21. A. Floth P. Schramek Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone J. Urol. 145 1991 56
22. C.M. Earle E.J. Keogh Z.S. Wisniewski A.G.S. Tulloch D.J. Lord G.R. Watters C. Glatthaar Prostaglandin E1 therapy for impotence, comparison with papaverine J. Urol. 143 1990 57
23. L.M. Lee R.W.D. Stevenson G. Szasz Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison J. Urol. 141 1989 549